IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v465y2010i7297d10.1038_nature09002.html
   My bibliography  Save this article

Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis

Author

Listed:
  • Yingdi Wang

    (Vascular Development Laboratory, Cancer Research UK London Research Institute)

  • Masanori Nakayama

    (Max-Planck-Institute for Molecular Biomedicine, and Faculty of Medicine, University of Münster)

  • Mara E. Pitulescu

    (Max-Planck-Institute for Molecular Biomedicine, and Faculty of Medicine, University of Münster)

  • Tim S. Schmidt

    (Vascular Development Laboratory, Cancer Research UK London Research Institute)

  • Magdalena L. Bochenek

    (Max-Planck-Institute for Molecular Biomedicine, and Faculty of Medicine, University of Münster
    School of Medical Sciences, University of Bristol)

  • Akira Sakakibara

    (Vascular Development Laboratory, Cancer Research UK London Research Institute)

  • Susanne Adams

    (Vascular Development Laboratory, Cancer Research UK London Research Institute
    Max-Planck-Institute for Molecular Biomedicine, and Faculty of Medicine, University of Münster)

  • Alice Davy

    (Centre de Biologie du Développement, Université de Toulouse, CNRS, CBD UMR 5547, F-31062 Toulouse cedex 9, France)

  • Urban Deutsch

    (Theodor Kocher Institute, University of Berne)

  • Urs Lüthi

    (Oncalis AG)

  • Alcide Barberis

    (Oncalis AG)

  • Laura E. Benjamin

    (Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215-5501, USA)

  • Taija Mäkinen

    (Cancer Research UK London Research Institute, Lymphatic Development Laboratory)

  • Catherine D. Nobes

    (School of Medical Sciences, University of Bristol)

  • Ralf H. Adams

    (Vascular Development Laboratory, Cancer Research UK London Research Institute
    Max-Planck-Institute for Molecular Biomedicine, and Faculty of Medicine, University of Münster)

Abstract

Ephrin-B2/VEGF in angiogenesis control Ephrin-B ligands are well known as axon guidance molecules. Ephrin-B2 is also known to play a role in angiogenic remodelling. Two studies now show that signalling through ephrin-B2 controls vessel sprouting. Mechanistically, ephrin-B2 seems to function in part by regulating VEGFR internalization and signalling. The finding suggests that blocking ephrin-B2 signalling may be an alternative approach to blocking VEGFR function in angiogenesis.

Suggested Citation

  • Yingdi Wang & Masanori Nakayama & Mara E. Pitulescu & Tim S. Schmidt & Magdalena L. Bochenek & Akira Sakakibara & Susanne Adams & Alice Davy & Urban Deutsch & Urs Lüthi & Alcide Barberis & Laura E. Be, 2010. "Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis," Nature, Nature, vol. 465(7297), pages 483-486, May.
    • Handle: RePEc:nat:nature:v:465:y:2010:i:7297:d:10.1038_nature09002
    DOI: 10.1038/nature09002
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature09002
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature09002?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Fuchun Yang & Shiva Kalantari & Banzhan Ruan & Shaogang Sun & Zhaoqun Bian & Jun-Lin Guan, 2023. "Autophagy inhibition prevents lymphatic malformation progression to lymphangiosarcoma by decreasing osteopontin and Stat3 signaling," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    2. Jonas Stewen & Kai Kruse & Anca T. Godoi-Filip & Zenia & Hyun-Woo Jeong & Susanne Adams & Frank Berkenfeld & Martin Stehling & Kristy Red-Horse & Ralf H. Adams & Mara E. Pitulescu, 2024. "Eph-ephrin signaling couples endothelial cell sorting and arterial specification," Nature Communications, Nature, vol. 15(1), pages 1-23, December.
    3. M. Gabriele Bixel & Kishor K. Sivaraj & Melanie Timmen & Vishal Mohanakrishnan & Anusha Aravamudhan & Susanne Adams & Bong-Ihn Koh & Hyun-Woo Jeong & Kai Kruse & Richard Stange & Ralf H. Adams, 2024. "Angiogenesis is uncoupled from osteogenesis during calvarial bone regeneration," Nature Communications, Nature, vol. 15(1), pages 1-22, December.
    4. Rida Al-Rifai & Marie Vandestienne & Jean-Rémi Lavillegrand & Tristan Mirault & Julie Cornebise & Johanne Poisson & Ludivine Laurans & Bruno Esposito & Chloé James & Olivier Mansier & Pierre Hirsch & , 2022. "JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    5. Christina M. Termini & Amara Pang & Tiancheng Fang & Martina Roos & Vivian Y. Chang & Yurun Zhang & Nicollette J. Setiawan & Lia Signaevskaia & Michelle Li & Mindy M. Kim & Orel Tabibi & Paulina K. Li, 2021. "Neuropilin 1 regulates bone marrow vascular regeneration and hematopoietic reconstitution," Nature Communications, Nature, vol. 12(1), pages 1-17, December.
    6. Mehmet Can Uçar & Edouard Hannezo & Emmi Tiilikainen & Inam Liaqat & Emma Jakobsson & Harri Nurmi & Kari Vaahtomeri, 2023. "Self-organized and directed branching results in optimal coverage in developing dermal lymphatic networks," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    7. Hongyu Liu & Ran Duan & Xiaoyu He & Jincu Qi & Tianming Xing & Yahan Wu & Liping Zhou & Lingling Wang & Yujing Shao & Fulei Zhang & Huixing Zhou & Xingdong Gu & Bowen Lin & Yuanyuan Liu & Yan Wang & Y, 2023. "Endothelial deletion of PTBP1 disrupts ventricular chamber development," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    8. Eun-A Kwak & Christopher C. Pan & Aaron Ramonett & Sanjay Kumar & Paola Cruz-Flores & Tasmia Ahmed & Hannah R. Ortiz & Jeffrey J. Lochhead & Nathan A. Ellis & Ghassan Mouneimne & Teodora G. Georgieva , 2022. "βIV-spectrin as a stalk cell-intrinsic regulator of VEGF signaling," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    9. Kevin Boyé & Luiz Henrique Geraldo & Jessica Furtado & Laurence Pibouin-Fragner & Mathilde Poulet & Doyeun Kim & Bryce Nelson & Yunling Xu & Laurent Jacob & Nawal Maissa & Dritan Agalliu & Lena Claess, 2022. "Endothelial Unc5B controls blood-brain barrier integrity," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    10. Wiebke Sachs & Lukas Blume & Desiree Loreth & Lisa Schebsdat & Favian Hatje & Sybille Koehler & Uta Wedekind & Marlies Sachs & Stephanie Zieliniski & Johannes Brand & Christian Conze & Bogdan I. Flore, 2024. "The proteasome modulates endocytosis specifically in glomerular cells to promote kidney filtration," Nature Communications, Nature, vol. 15(1), pages 1-21, December.
    11. Shujuan Zhao & Kedous Y. Mekbib & Martijn A. Ent & Garrett Allington & Andrew Prendergast & Jocelyn E. Chau & Hannah Smith & John Shohfi & Jack Ocken & Daniel Duran & Charuta G. Furey & Le Thi Hao & P, 2023. "Mutation of key signaling regulators of cerebrovascular development in vein of Galen malformations," Nature Communications, Nature, vol. 14(1), pages 1-23, December.
    12. Kuo-Sheng Hsu & James M. Dunleavey & Christopher Szot & Liping Yang & Mary Beth Hilton & Karen Morris & Steven Seaman & Yang Feng & Emily M. Lutz & Robert Koogle & Francesco Tomassoni-Ardori & Saurabh, 2022. "Cancer cell survival depends on collagen uptake into tumor-associated stroma," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    13. Hongryeol Park & Jian Song & Hyun-Woo Jeong & Max L. B. Grönloh & Bong Ihn Koh & Esther Bovay & Kee-Pyo Kim & Luisa Klotz & Patricia A. Thistlethwaite & Jaap D. Buul & Lydia Sorokin & Ralf H. Adams, 2024. "Apelin modulates inflammation and leukocyte recruitment in experimental autoimmune encephalomyelitis," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    14. Sandra Schrenk & Lindsay J. Bischoff & Jillian Goines & Yuqi Cai & Shruti Vemaraju & Yoshinobu Odaka & Samantha R. Good & Joseph S. Palumbo & Sara Szabo & Damien Reynaud & Catherine D. Raamsdonk & Ric, 2023. "MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQ," Nature Communications, Nature, vol. 14(1), pages 1-20, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:465:y:2010:i:7297:d:10.1038_nature09002. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.